Smilax Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 11-12-2024
- Paid Up Capital ₹ 1.40 Cr
as on 11-12-2024
- Company Age 33 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.00 M
as on 11-12-2024
- Revenue %
(FY 2018)
- Profit -131.52%
(FY 2018)
- Ebitda 67.55%
(FY 2018)
- Net Worth -0.09%
(FY 2018)
- Total Assets -0.10%
(FY 2018)
About Smilax Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.40 Cr.
The company has closed loans amounting to ₹5.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mukut Goyal and Mukta Goyal serve as directors at the Company.
- CIN/LLPIN
U24232RJ1991PTC006078
- Company No.
006078
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 1991
- Date of AGM
02 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Smilax Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukut Goyal  | Director | 08-Jul-1991 | Current |
| Mukta Goyal | Director | 08-Jul-1991 | Current |
Financial Performance of Smilax Pharmaceuticals.
Smilax Pharmaceuticals Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 131.52% decrease in profit. The company's net worth dipped by a decrease of 0.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Smilax Pharmaceuticals?
In 2018, Smilax Pharmaceuticals had a promoter holding of 64.29% and a public holding of 35.71%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Wright Care Drugs Private LimitedActive 20 years 2 months
Mukut Goyal and Mukta Goyal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 26 Mar 2009 | ₹5.00 M | Satisfied |
How Many Employees Work at Smilax Pharmaceuticals?
Unlock and access historical data on people associated with Smilax Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Smilax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smilax Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
